# Ernexa Therapeutics Inc.: Form 8-K, filed Oct 1, 2018

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2018-10-01
- Accepted by EDGAR: Oct 1, 2018, 08:30 ET
- Period: 2018-09-28
- Accession: 0001493152-18-013929
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315218013929/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315218013929/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315218013929/form8-k.htm

Filed Oct 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001493152-18-013929. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.